Cleared Traditional

Extension Set (K230528) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K230528 · Medcaptain Life Science Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
277d
Days
Class 2
Risk

K230528 is an FDA 510(k) clearance for the Extension Set. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Medcaptain Life Science Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on December 1, 2023 after a review of 277 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Medcaptain Life Science Co., Ltd. devices

Submission Details

510(k) Number K230528 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 2023
Decision Date December 01, 2023
Days to Decision 277 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
148d slower than avg
Panel avg: 129d · This submission: 277d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 238
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K230528.
Disposable Extension Set
K222766 · Shandong Ande Healthcare Apparatus Co., Ltd. · Apr 2024
Insignis™ Syringe Infusion System
K232328 · Innovative Health Sciences, LLC · Mar 2024
ResQ Administration Set
K231707 · Q For Plastic Industries · Jan 2024
LILY Extension Tube and Needleless Connector
K222780 · Lily Medical Corporation · Nov 2023
ProSeal™ Closed System Administration Set
K230343 · Epic Medical Pte. , Ltd. · Nov 2023
BD Alaris™ Pump Infusion Sets
K221327 · Care Fusion · Jul 2023